Investment
Features
FeesSafety
Academy
More
Pluang+

Compare uniQure N.V. Ordinary Shares (QURE) vs Workday Inc (WDAY) Price & Performance

uniQure N.V. Ordinary SharesTrade
Workday IncTrade

Price performance (Past 24H)

Key statistics

uniQure N.V. Ordinary Shares vs Workday Inc — how do they compare? uniQure N.V. Ordinary Shares trades at $21.71 (market cap $1.45B), while Workday Inc trades at $198.09 (market cap $45.49B). The key difference: Workday Inc is far larger — about 31.4× uniQure N.V. Ordinary Shares's market cap, and Workday Inc is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Workday Inc for 38 Days on average.

QUREWDAY
Market Cap
$1.45B$45.49B
Volume
3,323,2432,761,817
Sector
HealthTechnology
52-Week High
$70.59$245.67
52-Week Low
$9.03$112.55
Typical Hold Time
0 Days38 Days
Enterprise Value
$707.46M$45.86B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Workday Inc

Workday (WDAY) trades at $186.02, down 1.18% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $8.45B in 2025, and net income margin improved to 12.32%. Recent news highlights AI product launches and strategic partnerships, alongside a workforce reduction to align for growth.

The outlook remains positive with a consensus price target of $201.85, implying upside potential. Key opportunities include AI-driven revenue growth and market expansion, but risks involve integration costs, competitive pressures, and macroeconomic sensitivity. Analyst sentiment is predominantly buy-rated, supporting a constructive view for long-term investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QURE
100% Buy0% Sell
Avg holding period · 0 Days
WDAY

No sentiment data available yet.

Top news

Latest headlines on both assets

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →

About Workday Inc

Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.

Read more on WDAY →